{"filing":{"accession_number":"0001100682-26-000142","cik":"0001100682","ticker":"CRL","company_name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","form":"8-K","filing_date":"2026-09-24","report_date":"2026-09-24","primary_document":"crl-20260924.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1100682/000110068226000142/crl-20260924.htm"},"events":[{"id":34758,"run_id":32003,"accession_number":"0001100682-26-000142","anchor_item_number":"7.01","event_type":"operational_other","event_domain":"operational","is_material":true,"confidence":0.75,"summary":"Charles River disclosed a refreshed strategic vision (\"Pathway to Purpose\") at its 2026 Investor Day, outlining three strategic initiatives: modernizing operations through the \"Create the Future™\" program (targeting $300M+ in cumulative savings 2027-2030), strengthening scientific portfolio through organic and inorganic investments, and enhancing client-centric capabilities via the Apollo platform. The company reaffirmed 2026 guidance and introduced long-term financial targets through 2030 (5-7% organic revenue CAGR, ~24% non-GAAP operating margin). While this includes forward-looking financial targets, the core disclosure centers on operational and strategic business initiatives rather than a discrete financial event, M\u0026A activity, or governance change, making operational_other the most appropriate classification.","company_name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","ticker":"CRL","filing_date":"2026-09-24","form":"8-K","submitted_at":null,"items":[{"id":38591,"accession_number":"0001100682-26-000142","item_number":"7.01","item_title":"Regulation FD Disclosure","event_type":"operational_other","event_domain":"operational","is_material":true,"confidence":0.75,"reasoning":"Charles River disclosed a refreshed strategic vision (\"Pathway to Purpose\") at its 2026 Investor Day, outlining three strategic initiatives: modernizing operations through the \"Create the Future™\" program (targeting $300M+ in cumulative savings 2027-2030), strengthening scientific portfolio through organic and inorganic investments, and enhancing client-centric capabilities via the Apollo platform. The company reaffirmed 2026 guidance and introduced long-term financial targets through 2030 (5-7% organic revenue CAGR, ~24% non-GAAP operating margin). While this includes forward-looking financial targets, the core disclosure centers on operational and strategic business initiatives rather than a discrete financial event, M\u0026A activity, or governance change, making operational_other the most appropriate classification.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-09-24T13:05:41.705370+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":38591,"accession_number":"0001100682-26-000142","item_number":"7.01","item_title":"Regulation FD Disclosure","event_type":"operational_other","event_domain":"operational","is_material":true,"confidence":0.75,"reasoning":"Charles River disclosed a refreshed strategic vision (\"Pathway to Purpose\") at its 2026 Investor Day, outlining three strategic initiatives: modernizing operations through the \"Create the Future™\" program (targeting $300M+ in cumulative savings 2027-2030), strengthening scientific portfolio through organic and inorganic investments, and enhancing client-centric capabilities via the Apollo platform. The company reaffirmed 2026 guidance and introduced long-term financial targets through 2030 (5-7% organic revenue CAGR, ~24% non-GAAP operating margin). While this includes forward-looking financial targets, the core disclosure centers on operational and strategic business initiatives rather than a discrete financial event, M\u0026A activity, or governance change, making operational_other the most appropriate classification.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-09-24T13:05:41.705370+00:00","company_name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","ticker":"CRL","filing_date":"2026-09-24"}]}